Weil Company’s VirnetX Holding Corp VHC Stock Holding History

Weil Company’s Portfolio VHC Stock Details VHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-200	Closed	-$22K	–	324
2019 Q3	$22K	Buy	+200	New	+$23.8K	0.02%	239

Other funds holding VHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Weil Company's VHC Position: Q4 2019 in Review

Weil Company sold out of VirnetX Holding Corp (VHC) in Q4 2019, closing a stake of 200 shares — an estimated $22K sold.

Weil Company first reported a position in VHC in Q3 2019 and held it in 1 quarter. The position peaked at $22K in Q3 2019. 81 funds tracked by Wall St. Rank hold VHC as of Q4 2019.

Weil Company reported no remaining VirnetX Holding Corp position as of Q4 2019 after selling out during the quarter.
Weil Company sold 200 VirnetX Holding Corp shares in Q4 2019, an estimated $22K.
Weil Company first reported a position in VirnetX Holding Corp in Q3 2019 and held it in 1 quarter.
Weil Company's VirnetX Holding Corp position peaked at $22K in Q3 2019.
81 funds tracked by Wall St. Rank held VirnetX Holding Corp as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.